Characterizing the Mesencephalon Using Susceptibility-Weighted Imaging

References

1. ↵
   Sofic E, Paulus W, Jellinger K, et al. Selective increase of iron in substantia nigra zona compacta in parkinsonian brains. J Neurochem 1991;56:978–82

   CrossRefPubMedWeb of Science
2. ↵
   Sohmiya M, Tanaka M, Aihara Y, et al. Structural changes in the midbrain with aging and Parkinson's disease: an MRI study. Neurobiol Aging 2004;25:449–53

   CrossRefPubMed
3. Semnic R, Svetel M, Dragasevic N, et al. Magnetic resonance imaging morphometry of the midbrain in patients with Wilson disease. J Comput Assist Tomogr 2005;29:880–83

   CrossRefPubMed
4. Kim E, Na DG, Kim EY, et al. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 2007;28:1652–58. Epub 2007 Sep 20

   Abstract/FREE Full Text
5. ↵
   Sohmiya M, Tanaka M, Aihara Y, et al. Age-related structural changes in the human midbrain: an MR image study. Neurobiol Aging 2001;22:595–601

   CrossRefPubMed
6. ↵
   Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Neuroradiology 1999;210:759–67
7. ↵
   Mugler JP, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15:152–57

   CrossRefPubMedWeb of Science
8. ↵
   Frahm J, Haase A, Matthei D, et al. FLASH imaging: rapid imaging using low flip angle pulses. J Magn Reson Imaging 1986;67:256–66
9. ↵
   Shibata E, Sasaki M, Tohyama K, et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006;17:1215–18

   CrossRefPubMedWeb of Science
10. ↵
    Reichenbach JR, Venkatesan R, Schillinger DJ, et al. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–77

    PubMedWeb of Science
11. ↵
    Haacke EM, Xu Y, Cheng YN, et al. Susceptibility-weighted imaging (SWI). Magn Reson Med 2004;52:612–18

    CrossRefPubMedWeb of Science
12. ↵
    Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging for determining normal versus abnormal iron content in the brain. J Magn Reson Imaging 2007;26:256–64

    CrossRefPubMedWeb of Science
13. Abduljalil AM, Schmalbrock P, Novak V, et al. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging 2003;18:284–90

    CrossRefPubMedWeb of Science
14. Rauscher A, Sedlacik J, Barth M, et al. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736–42

    Abstract/FREE Full Text
15. ↵
    Chakeres DW, Abduljalil AM, Novak P, et al. Comparison of 1.5 and 8 Tesla high-resolution magnetic resonance imaging of lacunar infarcts. J Comput Assisted Tomogr 2002;26:628–32

    CrossRefPubMed
16. ↵
    Duvernoy HM. Human Brain Stem Vessels. 2nd ed. Berlin, Germany: Springer-Verlag;1999 :206–13
17. ↵
    Ogg R, Langston J, Haacke EM, et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17:1141–48

    CrossRefPubMedWeb of Science
18. ↵
    Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25

    CrossRefPubMedWeb of Science
19. ↵
    Morris CM, Candy JM, Oakley AE, et al. Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 1992;144:235–57

    PubMedWeb of Science